4//SEC Filing
KEMPHARM, INC 4
Accession 0001437749-17-010012
$ZVRACIK 0001434647operating
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:32 PM ET
Size
15.7 KB
Accession
0001437749-17-010012
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Thompson Danny L
Director
Transactions
- Award
Stock Option (right to buy)
2017-05-23+10,000→ 10,000 totalExercise: $3.95Exp: 2027-05-22→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Market on the date of grant, May 23, 2017.
- [F2]This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy.
- [F3]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.
Issuer
KEMPHARM, INC
CIK 0001434647
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434647
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:32 PM ET
- Size
- 15.7 KB